by James Dye | Apr 17, 2024 | Press Releases
*Presentation to be held on Wednesday, April 24, from 2:00 – 2:15 p.m. SGT LEHI, Utah, April 17, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat... by James Dye | Apr 1, 2024 | News & Media
Beyond Employee Engagement: Unpacking Performance in Life Sciences Leadership – Executive Roundtable April 1, 2024 In this insightful episode of Conversations Life Science Leaders Aren’t Having, Jeff Harmon hosts an invaluable Life Science Executive... by James Dye | Mar 21, 2024 | News & Media
March 20, 2024/28:57/E24012 In this episode of BioTech Nation, Dr. David Bearss, President, and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered... by James Dye | Mar 12, 2024 | Press Releases
Presentation to be held on Tuesday, March 19, from 11:30 a.m. – 11:45 a.m. CET LEHI, Utah, March 12, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule... by James Dye | Feb 21, 2024 | Press Releases
LEHI, Utah, Feb. 21, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced that David J. Bearss, Ph.D., President and CEO of...